Patients with cancer in the UK often have multiple consultations with their family doctor before diagnosis, which is partly due to different symptoms each cancer type presents. Tumours with one main symptom and a simple investigative pathway are easier to diagnose, but structural investigational barriers also contribute to delayed diagnosis.
The UK has a poor record in cancer outcomes, much of which is blamed on delays in diagnosis. 1 Screening only identifies around 10% of cancers, thus most patients with cancer present after symptoms begin. The first contact with health-care is usually through family doctors known as general practitioners (GPs). UK has a strong 'gatekeeper' system, whereby access to specialist care requires referral from a GP. A similar system exists in Denmark, which also has a poor record in cancer survival. 2 GPs have long been blamed by their patients for 'missing cancer'-which is true in some cases-but the structure of the health-care system, rather than individual medical errors, could delay the diagnosis. So, the question is whether to blame the system or the doctors.
In their recent paper, Lyratzopoulos et al. 3 have given ammunition to the critics of UK general practice with their secondary analysis of the Cancer Patient Experience Survey that was carried out in England in 2010. Over 41,000 patients newly diagnosed with one of the 24 most common types of cancers (including breast, lung, ovarian and testicular cancers, melanoma, and myeloma) reported the number of GP consultations they had with a symptom before the diagnosis was made. Nearly 25% of the patients had three or more consultations. This finding was treated as a binary outcome, and although the authors did not openly state so in their paper, they implied that three or more consultations was poor medical practice, and fewer than three consultations was satisfactory. Among other cancers, myeloma diagnosis was most strongly associated with multiple consultations, closely followed by pancreatic and stomach cancers. By contrast, breast cancer, melanoma and testicular cancer had the least number of patients who had multiple consultations before the diagnosis was made. Younger patients, particularly those aged 16-24 years old, those from non-white ethnic groups and women were more likely to require three or more consultations before diagnosis.
Ascribing these results as a rank of ease of diagnosis would be a simplistic approach, although this is clearly one aspect. Several factors explain the low number of consultations before breast cancer diagnosis: most symptomatic breast cancers are palpable and most women know of and dread breast cancer, thus they expect the doctors to discuss the possibility explicitly. Additionally, GPs in the UK are expected to refer all women with breast symptoms to a specialist for consideration of cancer. This referral model works reasonably well for cancer types that are associated with one main symptom, are well understood by the public and can be identified by simple and accurate diagnostic tests in the specialist clinic. Even so, GPs worry about losing their diagnostic skills in breast conditions, and surgeons complain that the number of women who transpire to have breast cancer in their clinics is falling. 4 Few other types of cancers fit this referral model, except melanoma and testicular and urological cancers presenting with haematuria. 5 Two separate explanations exist for the type of cancers associated with the worst record of diagnosis. The first explanation is that in some tumour types, including myeloma, the GP might not consider the possibility of cancer after the first (or subsequent) consultation if the patient presents with bone pain. A good primary-care test is available to identify myeloma, such as the plasma viscosity test followed by protein electro phoresis in patients with a viscosity >1.7 mPa/s. For this reason, the high frequency of multiple consultations before diagnosis of myeloma is most likely due to lack of consideration of the possibility of cancer, rather than unavailability of testing.
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If the patient has a raised plasma viscosity, repeat consultations with a GP should not be required, other than to explain the implications of the test result, and to organise further investigations. Public awareness of myeloma and its symptoms is very low; therefore, if the GP does not consider myeloma as a possibility during consultation, diagnosis will be delayed. Lung and ovarian cancers can be identified with simple tests (chest X-ray for lung cancer, and trans-vaginal ultrasound and CA-125 blood test for ovarian cancer), although each of these cancers presents with several different symptoms. 6 Once the GP considers cancer as a possibility, diagnosis should be straightforward; however, lung and ovarian cancers also seem to require multiple consultations before diagnosis, 3 again probably because the possibility of cancer is not initially considered.
The second explanation for a delayed diagnosis is the 'low-risk-but-not-norisk' symptom, the classic example being colorectal cancer. Less than 50% of patients present with a high-risk symptom, such as rectal bleeding or severe anaemia. 7 The GPs might consider the possibility of cancer early in a patient presenting with diarrhoea or constipation. If a primary-care test was available for colorectal cancer with sufficient specificity to allow the GP to avoid definitive investigation, such as colonoscopy, then it would be useful. However, no primary-care test exists for colorectal cancer, and as the GPs know that the risk of cancer is small, most patients are not investigated. This type of practice is fine if the patient does not have cancer. Inevitably, however, a small number of patients who have cancer experience diagnostic delay.
The UK has structural barriers to investigation for suspected cancer cases. Rapid investigation clinics are available for all cancers, but only if the patient has the 'right' symptom. If the patient presents with the 'wrong' symptom, such as abdominal pain with colorectal cancer, then the risk of mortality increases. 8 These barriers are being dismantled. GPs in the UK will soon have easy access to colonoscopy, transvaginal ultrasonography and MRI equipment, (but not abdominal CT, at least for now). The use of CA-125 test has mushroomed since it became widely available and since it was recommended by the National Institute of Health and Clinical Excellence for use in patients presenting with symptoms of possible ovarian cancer.
All these initiatives reduced the threshold for testing in primary care, but each test has a cost. Although the cost is low-the cost of CA-125 test for UK National Health Service (NHS) is published to be £23, but is currently considerably less-it is not negligible, particu larly in a time of financial retrenchment in the NHS. The twist in the recent NHS reorganisation will give the GPs in UK the responsibility for commissioning investigative services. Whether the daily experience of the GPs with cancer will encourage them to expand testing for possible cancer cases or whether researchers such as Lyratzopoulos et al. will report further data on variations in GP consultations before cancer diagnosis remains unclear. The outcome will reveal the success of the NHS reforms, which are based on the theory that GPs have the best know ledge of what their patients need. 
